Tezepelumab in severe asthma: a profile of its use Yahiya Y. Syed Adis Drug Q&A Open access 07 December 2023 Pages: 393 - 403
Spesolimab in generalised pustular psoriasis flares: a profile of its use Tina Nie Adis Drug Q&A 02 December 2023 Pages: 404 - 412
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use Matt Shirley Adis Drug Q&A 22 December 2023 Pages: 413 - 420
Manage vitiligo with a personalised approach: consider old and new treatments Nicole L. France Disease Management 24 November 2023 Pages: 421 - 425
Understand the benefits and risks of intravenous methadone for perioperative and chronic cancer pain management Tina Nie Practical Issues and Updates 13 December 2023 Pages: 426 - 431
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients Elisabetta MunzoneAlessandra FabiMichelino De Laurentiis Original Research Article Open access 21 December 2023 Pages: 432 - 446
Correction to: RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA Hannah A. Blair Correction Open access 24 November 2023 Pages: 447 - 447
